Viro-Immunologic Response to Ritonavir-Boosted or Unboosted Atazanavir in a Large Cohort of Multiply Treated Patients: The CARe Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Viro-Immunologic Response to Ritonavir-Boosted or Unboosted Atazanavir in a Large Cohort of Multiply Treated Patients: The CARe Study

Published:2008-01 Issue:1 Volume:22 Page:7-16
ISSN:1087-2914
Container-title:AIDS Patient Care and STDs
language:en
Short-container-title:AIDS Patient Care and STDs

Author:

Santoro Maria Mercedes¹,Bertoli Ada¹,Lorenzini Patrizia²,Lazzarin Adriano³,Esposito Roberto⁴,Carosi Giampiero⁵,Di Perri Giovanni⁶,Filice Gaetano⁷,Moroni Mauro⁸,Rizzardini Giuliano⁸,Caramello Pietro⁹,Maserati Renato⁷,Narciso Pasquale²,Cargnel Antonietta⁸,Antinori Andrea²,Perno Carlo Federico²,

Affiliation:

1. University of Tor Vergata, Rome, Italy.

2. INMI, Lazzaro Spallanzani, Rome, Italy.

3. IRCCS, San Raffaele, Milan, Italy.

4. University of Modena, Modena, Italy.

5. University of Brescia, Brescia, Italy.

6. University of Turin, Turin, Italy.

7. IRCCS, San Matteo, Pavia, Italy.

8. Institute of Infectious and Tropical Diseases, L. Sacco Hospital, Milan, Italy.

9. Clinic of Infectious diseases, Hospital Amedeo di Savoia, Turin, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/apc.2007.0013

Reference24 articles.

1. Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individuals

2. Prospective Randomized Two-Arm Controlled Study To Determine the Efficacy of a Specific Intervention To Improve Long-Term Adherence to Highly Active Antiretroviral Therapy

3. Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA

4. High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors involved in continuance of atazanavir-based regimens: Results from a cohort of HIV1-positive patients;Antiviral Research;2016-05

2. Long-term Safety and Efficacy of Atazanavir-based Therapy in HIV-infected Infants, Children and Adolescents;Pediatric Infectious Disease Journal;2015-02

3. Population pharmacokinetics of atazanavir/ritonavir in HIV-1-infected children and adolescents;British Journal of Clinical Pharmacology;2011-11-09

4. Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults;Future Virology;2011-02

5. Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-infected Koreans;Infection and Chemotherapy;2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3